HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Irvingia gabonensis Seed Extract: An Effective Attenuator of Doxorubicin-Mediated Cardiotoxicity in Wistar Rats.

Abstract
Cardiotoxicity as an off-target effect of doxorubicin therapy is a major limiting factor for its clinical use as a choice cytotoxic agent. Seeds of Irvingia gabonensis have been reported to possess both nutritional and medicinal values which include antidiabetic, weight losing, antihyperlipidemic, and antioxidative effects. Protective effects of Irvingia gabonensis ethanol seed extract (IGESE) was investigated in doxorubicin (DOX)-mediated cardiotoxicity induced with single intraperitoneal injection of 15 mg/kg of DOX following the oral pretreatments of Wistar rats with 100-400 mg/kg/day of IGESE for 10 days, using serum cardiac enzyme markers (cardiac troponin I (cTI) and lactate dehydrogenase (LDH)), cardiac tissue oxidative stress markers (catalase (CAT), malonyldialdehyde (MDA), superoxide dismutase (SOD), glutathione-S-transferase (GST), glutathione peroxidase (GSH-Px), and reduced glutathione (GSH)), and cardiac histopathology endpoints. In addition, both qualitative and quantitative analyses to determine IGESE's secondary metabolites profile and its in vitro antioxidant activities were also conducted. Results revealed that serum cTnI and LDH were significantly elevated by the DOX treatment. Similarly, activities of tissue SOD, CAT, GST, and GSH levels were profoundly reduced, while GPx activity and MDA levels were profoundly increased by DOX treatment. These biochemical changes were associated with microthrombi formation in the DOX-treated cardiac tissues on histological examination. However, oral pretreatments with 100-400 mg/kg/day of IGESE dissolved in 5% DMSO in distilled water significantly attenuated increases in the serum cTnI and LDH, prevented significant alterations in the serum lipid profile and the tissue activities and levels of oxidative stress markers while improving cardiovascular disease risk indices and DOX-induced histopathological lesions. The in vitro antioxidant studies showed IGESE to have good antioxidant profile and contained 56 major secondary metabolites prominent among which are γ-sitosterol, Phytol, neophytadiene, stigmasterol, vitamin E, hexadecanoic acid and its ethyl ester, Phytyl palmitate, campesterol, lupeol, and squalene. Overall, both the in vitro and in vivo findings indicate that IGESE may be a promising prophylactic cardioprotective agent against DOX-induced cardiotoxicity, at least in part mediated via IGESE's antioxidant and free radical scavenging and antithrombotic mechanisms.
AuthorsOlufunke Olorundare, Adejuwon Adeneye, Akinyele Akinsola, Phillip Kolo, Olalekan Agede, Sunday Soyemi, Alban Mgbehoma, Ikechukwu Okoye, Ralph Albrecht, Hasan Mukhtar
JournalOxidative medicine and cellular longevity (Oxid Med Cell Longev) Vol. 2020 Pg. 1602816 ( 2020) ISSN: 1942-0994 [Electronic] United States
PMID33149803 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Olufunke Olorundare et al.
Chemical References
  • Antioxidants
  • Biomarkers
  • Biphenyl Compounds
  • Free Radical Scavengers
  • Lipids
  • Phytochemicals
  • Picrates
  • Plant Extracts
  • dikanut
  • Nitric Oxide
  • Doxorubicin
  • Cellulose
  • 1,1-diphenyl-2-picrylhydrazyl
  • Ascorbic Acid
Topics
  • Animals
  • Antioxidants (pharmacology)
  • Ascorbic Acid (pharmacology)
  • Biomarkers (metabolism)
  • Biphenyl Compounds (chemistry)
  • Cardiotoxicity (blood, drug therapy)
  • Cellulose (chemistry)
  • Doxorubicin (adverse effects)
  • Free Radical Scavengers (chemistry)
  • Gas Chromatography-Mass Spectrometry
  • Lipids (blood)
  • Male
  • Metabolome
  • Myocardium (pathology)
  • Nitric Oxide (metabolism)
  • Oxidative Stress (drug effects)
  • Phytochemicals (analysis)
  • Picrates (chemistry)
  • Plant Extracts (pharmacology, therapeutic use)
  • Rats, Wistar
  • Risk Factors
  • Secondary Metabolism (drug effects)
  • Seeds (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: